In a hospital ward, a stroke has already happened, and the question of what comes next weighs on everyone who must decide. A recent study in Neurology looked at nearly fourteen thousand people who had suffered a blocked-artery stroke while living with an irregular heartbeat, and found that those whose rhythm was restored early, within eight weeks, tended to fare better over the following years. The researchers were careful to say that this is a pattern in the records, not a proven cure, since only a small handful of patients received the treatment at all. It is a hopeful clue in an old human s
Early Heart Rhythm Restoration After Stroke Is Linked to Fewer Repeat Strokes, Study Finds
Patients with ischemic stroke and atrial fibrillation face elevated risk of a second stroke or systemic embolism, with about 1,257 such events recorded over the study period.
Only 268 of 14,355 patients received early rhythm control
Mark
So what is the headline here, in plain terms?
Mimi
Stroke patients with atrial fibrillation who had their heart rhythm restored within eight weeks had a lower risk of another stroke or clot. Five-year risk was 8% versus 14%.
Mark
That sounds large. A 44% lower risk.
Luke
It is large, but look at the base. Only 268 of 14,355 people got early rhythm control, about 2%. And just 13 of the 1,257 events happened in that group. Small counts can swing a lot.
Mimi
The authors say as much. Small numbers of treated patients are the stated limitation, and they want larger studies.
Mark
Does this mean the treatment prevents strokes?
Luke
No. The study says it only shows an association. The researchers adjusted for frailty, stroke severity and other conditions, but I can't tell from this reporting what might still differ between the groups.
Mark
Who were these patients?
Mimi
Average age was 83, all hospitalized with both ischemic stroke and AFib. That is an older group than many trials enroll.
Luke
And the source doesn't say why some got rhythm control and others didn't. That is unknown here.
Mark
How does this fit with anticoagulants?
Mimi
Anticoagulants remain the standard after stroke. Imanaka frames rhythm control as a possible added strategy, not a replacement.
Il Polso
- A stroke has already struck, and the clock for preventing another one is running out after eight weeks.
- Nearly 14,000 hospitalized patients with irregular heartbeats were tracked, and only 268 received early rhythm control.
- Doctors are weighing medication, electrical shocks, and catheter ablation as possible second lines of defense beside blood thinners.
- The apparent drop in second strokes and deaths is promising, yet the researchers insist it is only an association and not proof.
In a hospital ward, a stroke has already happened, and the question of what comes next weighs on everyone who must decide. A recent study in Neurology looked at nearly fourteen thousand people who had suffered a blocked-artery stroke while living with an irregular heartbeat, and found that those whose rhythm was restored early, within eight weeks, tended to fare better over the following years. The researchers were careful to say that this is a pattern in the records, not a proven cure, since only a small handful of patients received the treatment at all. It is a hopeful clue in an old human struggle to keep a second blow from falling, and it waits for larger and more careful inquiry before it can be trusted to change practice.
A study published October 21, 2026, in Neurology reports that people hospitalized with both an ischemic stroke and atrial fibrillation fared better when their heart rhythm was restored early, within eight weeks of the stroke. Those patients were less likely to suffer another stroke or blood clot, and less likely to die. The authors state plainly that the link is an association, not proof that early treatment prevents a second stroke.
Rhythm control can be achieved through medication, electrical cardioversion, or catheter ablation, which uses heat, cold, or electricity to block faulty electrical signals. Yuichi Imanaka of Kyoto University noted that such treatment is known to help people with atrial fibrillation alone, but far less was understood for those with both conditions.
The team examined 14,355 people, averaging 83 years old. Only 268 of them, about 2%, received early rhythm control. Across more than 23,000 person-years of follow-up, 1,257 suffered a second stroke or systemic embolism, only 13 of them in the treated group. After adjusting for health conditions, frailty, and stroke severity, the five-year risk was 8% for the treated and 14% for the untreated, a 44% reduction, with a 28% lower death rate.
Imanaka suggests the approach could complement anticoagulants, which these patients already take, as an additional safeguard with flexible timing. Yet he and his colleagues stress that the small number of treated patients limits certainty, and larger studies must confirm the findings before any change in practice.
A study published October 21, 2026, in Neurology, the journal of the American Academy of Neurology, reports that people hospitalized with both an ischemic stroke and atrial fibrillation fared better if their heart rhythm was restored early. The window was within eight weeks of the stroke. Those who got that treatment were less likely to have another stroke or blood clot, and less likely to die.
The finding comes with a caveat the authors state plainly: the study shows an association, not proof that early rhythm control prevents a second stroke. Ischemic stroke, the most common kind, happens when blood flow to part of the brain is blocked. Atrial fibrillation is an irregular and often very rapid heartbeat.
Early rhythm control can take three forms. Medication is one. Electrical cardioversion, a quick electrical shock, is another. The third is catheter ablation, which uses heat, cold or electricity to create scar tissue that blocks abnormal electrical impulses. Study author Yuichi Imanaka of Kyoto University in Japan noted that in people with atrial fibrillation alone, restoring normal rhythm early lowers the risk of later cardiovascular events. Less has been known about people who have both conditions.
The researchers identified 14,355 people, with an average age of 83, who were admitted to a hospital with both ischemic stroke and atrial fibrillation. Only 2% of them, 268 people, received early rhythm control. Of those, 206 were given medication, 68 had catheter ablation and 32 had electrical cardioversion. Some patients received more than one treatment.
The team then tracked who was hospitalized again for a second ischemic stroke or a systemic embolism, meaning a clot that forms in another part of the body. Across 23,583 person-years of follow-up, a measure that combines the number of people and the time each spent in the study, 1,257 people had one of those events. Thirteen of them had received early rhythm control. The other 1,244 had not.
Because the two groups differed, the researchers used a statistical method to adjust for factors such as other medical conditions, frailty and stroke severity. After that adjustment, the five-year risk of a second stroke or blood clot was 8% for those who received early rhythm control and 14% for those who did not. That works out to a 44% lower risk of stroke and blood clot. Early rhythm control was also associated with a 28% lower risk of death from any cause.
Imanaka pointed out that people who have an ischemic stroke are already prescribed anticoagulants, drugs that keep blood from clotting easily, to prevent a second one. In his words, the results suggest early rhythm control may be an additional prevention strategy, with flexible timing, as long as it begins within eight weeks of the stroke.
The main limitation is the small number of patients who actually received early rhythm control. Imanaka says larger studies are needed to confirm the findings. The work was supported by the Japan Society for the Promotion of Science.
Citazioni salienti
Early rhythm control may serve as another prevention strategy, with flexible timing, within eight weeks of stroke.— Yuichi Imanaka, MD, MPH, PhD, Kyoto University (paraphrased)
Vuoi la storia completa?
Leggi l'originale su News-Medical ↗
Science & Space